13F-HR filed by Exome Asset Management LLC
Exome Asset Management LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-15, with 52 holding rows worth $101,142,934.
- Accession
- 0001420506-24-000483
- Filer
- CIK 2011932
- Filed
- 2024-02-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 52 entries on the cover page, a total value of $101,142,934 stated on the cover page (in dollars after the unit check, H1), rows summing to $101,142,934 with VALUE read as dollars as filed, 13F file number 028-23951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 90,000 | $6,262,200 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 9,700 | $5,654,324 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 186,900 | $5,541,585 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 15,300 | $4,581,585 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 111,300 | $4,414,158 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 203,300 | $3,472,364 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 72,203 | $3,319,172 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 173,500 | $3,306,910 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 24,828 | $3,080,907 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 13,202 | $3,054,679 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 34,908 | $2,914,469 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 73,158 | $2,780,004 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 68,100 | $2,775,756 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 91,800 | $2,751,246 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 65,113 | $2,628,612 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 12,800 | $2,308,608 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 37,900 | $2,280,443 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 8,553 | $2,151,422 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 6,358 | $2,144,935 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 8,200 | $2,121,914 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 28,300 | $2,026,846 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 45,467 | $1,945,988 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 61,500 | $1,905,885 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 29,100 | $1,804,200 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 105,500 | $1,773,455 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 84,400 | $1,709,100 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 223,300 | $1,592,129 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 3,900 | $1,586,871 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 129,900 | $1,367,847 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 36,384 | $1,322,195 | dollars as filed | |
| GERON CORP | 374163103 | COM | 607,500 | $1,281,825 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 693,300 | $1,227,141 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 125,900 | $1,211,158 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 18,650 | $1,168,236 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 135,596 | $1,126,803 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 46,700 | $1,060,090 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 15,896 | $933,890 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 49,580 | $897,894 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 35,257 | $764,019 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 4,000 | $762,240 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 83,987 | $755,043 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 75,300 | $738,693 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 27,600 | $714,564 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 153,600 | $658,944 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 26,400 | $610,104 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 9,744 | $588,440 | dollars as filed | |
| PROCAPS GROUP SA | L7756P102 | SHS | 126,901 | $516,487 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 7,249 | $433,925 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 40,974 | $411,379 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 118,100 | $275,173 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 178,404 | $228,357 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 83,848 | $198,720 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000483 | this filing | 2024-02-15 | acceptance time not in the bulk data set |